← Human Trials & Peer-Reviewed Studies
Intranasal oxytocin and the stress-buffering effects of social support during experimentally induced pain: The role of attachment security
Plain-language guide to PMID 32961410 (2021): double-blind randomized controlled trial study of Oxytocin.
Key Facts
- PMID
- 32961410
- Journal
- Journal of affective disorders
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Riem MME et al. (3 authors)
- DOI
- 10.1016/j.jad.2020.09.057
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Oxytocin.
Future studies are needed to determine sex differences in how oxytocin shapes stress-buffering effects of support.
Why It Was Studied
This study examined whether intranasal oxytocin enhances the stress-buffering effects of social support during experimentally induced pain, taking into account the role of individual differences in attachment security.
Only female participants were examined.
Who Took Part
PubMed tags the participants as both men and women.
Participants underwent the Cold Pressor Task (CPT) and were monitored for heart rate variability (HRV: RMSSD) and heart rate and reported pain levels.
The Experiences in Close Relationships Questionnaire was used to measure attachment.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Because people in this Oxytocin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Neither the participants nor the staff measuring them knew who was on Oxytocin, so expectations could not easily colour the readings.
A placebo (an inactive look-alike) gave the Oxytocin group a baseline to be compared against.
What Was Measured
Topics PubMed links to this paper include Oxytocin, Pain and Social Support.
The authors tagged it with the keywords Attachment, Cold pressor task and Heart rate variability.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Oxytocin.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (Journal of affective disorders), a journal based in Netherlands.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.